Torii Pharmaceutical Co., Ltd.

TSE:4551.T

4140 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 54,63848,89446,98741,69942,99762,55064,13460,20662,37743,50258,10852,29248,71645,33542,41637,34840,84439,57640,48341,914
Cost of Revenue 30,06525,51622,64819,96120,70231,84431,29330,28630,81320,58626,26622,84020,53818,60215,98413,64816,25015,37414,90115,608
Gross Profit 24,57323,37824,33921,73822,29530,70632,84129,92031,56422,91631,84229,45228,17826,73326,43223,70024,59424,20225,58226,306
Gross Profit Ratio 0.450.4780.5180.5210.5190.4910.5120.4970.5060.5270.5480.5630.5780.590.6230.6350.6020.6120.6320.628
Reseach & Development Expenses 3,4901,6618325962,9564,1384,6084,6545,2373,4006,6627,8244,6315,9941,6131,1911,8281,765911454
General & Administrative Expenses 2,0331,70700005815645705851,1312,3332,3833,3393,3212,3312,2945,7455,9035,870
Selling & Marketing Expenses 1,5821,5814,1873,3162,8335,1745,0915,0035,1473,6224,0423,7634,1793,7813,6843,3123,660000
SG&A 16,0471,5814,1873,3162,8335,1745,0915,0035,1473,6224,0426,0966,5627,1207,0055,6435,9545,7455,9035,870
Other Expenses 2014,59314,66013,08315,072245872493732373955445675110-182,582
Operating Expenses 19,53717,83519,67916,99520,86125,75226,55626,09726,64218,88226,85126,65324,01920,80316,30615,04915,89915,49514,77314,468
Operating Income 5,0365,5404,6564,7381,4304,9516,2813,8194,9194,0324,9872,7944,1531,8446,1254,8995,13912,2357,6068,499
Operating Income Ratio 0.0920.1130.0990.1140.0330.0790.0980.0630.0790.0930.0860.0530.0850.0410.1440.1310.1260.3090.1880.203
Total Other Income Expenses Net 557182111-51336,270-1,92192237339-251146135901-4,260-4,031-2,971-6,989-6,801-6,579-4,335
Income Before Tax 5,5935,7224,7674,22537,7003,0306,3734,0565,2583,7815,1332,9295,0541,8396,3406,0385,3785,4347,53710,115
Income Before Tax Ratio 0.1020.1170.1010.1010.8770.0480.0990.0670.0840.0870.0880.0560.1040.0410.1490.1620.1320.1370.1860.241
Income Tax Expense 1,4731,7781,39272910,3331,8651,6551,2161,7301,3611,7811,0792,4439012,6982,5612,4112,4063,3574,320
Net Income 4,1193,9443,3743,49527,3671,1644,7182,8393,5272,4193,3521,8492,6119373,6423,4762,9673,0284,1795,793
Net Income Ratio 0.0750.0810.0720.0840.6360.0190.0740.0470.0570.0560.0580.0350.0540.0210.0860.0930.0730.0770.1030.138
EPS 146.57140.38120.11124.47974.9941.49168.22100.41124.6585.5118.4765.3692.2733.11128.69122.84104.83106.99146.76203.83
EPS Diluted 146.57140.38120.11124.46974.9941.49168.22100.41124.6585.5118.4765.3692.2733.11128.69122.84104.83106.99146.76203.83
EBITDA 5,2716,0535,3185,5932,6766,1187,5775,3386,5915,0666,2134,0125,5337,49311,78010,42613,58713,36815,12215,408
EBITDA Ratio 0.0960.1240.1130.1340.0620.0980.1180.0890.1060.1160.1070.0770.1140.1650.2780.2790.3330.3380.3740.368